다우존스 지수

같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

등록

홈
인베스팅
주식
미국
NASDAQ
Hollis-Eden Pharmaceuticals (MM) (HEPH)
Hollis-Eden Pharmaceuticals (MM) (HEPH) 뉴스

HEPH

Hollis-Eden Pharmaceuticals (MM) (HEPH)

Hollis-Eden Pharmaceuticals (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:HEPH

1 2 3 4 5 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2010/02/18	06:03	PR Newswire (US)	Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR'	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/02/17	06:27	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/02/04	04:39	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/02/04	04:38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/02/04	04:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/02/04	04:37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/02/04	04:36	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/02/04	04:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/02/04	04:35	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2010/01/07	06:31	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3/A)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/12/23	06:38	Edgar (US Regulatory)	Securities Registration Statement (simplified form) (S-3)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/12/15	20:03	Edgar (US Regulatory)	Securities Registration (section 12(b)) (8-A12B)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/11/16	23:00	PR Newswire (US)	Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular Ta	NASDAQ:HEPH
2009/11/13	06:37	PR Newswire (US)	Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and Cancer	NASDAQ:HEPH
2009/11/07	07:23	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/10/22	19:05	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/10/20	22:11	PR Newswire (US)	Hollis-Eden Pharmaceuticals Retains Burrill LLC to Provide Exclusive Advisory Services for Lead Programs	NASDAQ:HEPH
2009/09/17	02:33	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/09/16	21:30	PR Newswire (US)	Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid Price	NASDAQ:HEPH
2009/08/14	19:06	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/06/16	04:52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/06/16	01:30	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/06/15	20:05	PR Newswire (US)	Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEO	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/06/12	05:54	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/06/06	05:06	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/05/14	19:03	Edgar (US Regulatory)	Quarterly Report (10-Q)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/05/08	06:00	Edgar (US Regulatory)	Proxy Statement (definitive) (DEF 14A)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/04/24	06:00	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/04/01	06:36	Business Wire	Hollis-Eden Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)
2009/04/01	06:30	Edgar (US Regulatory)	Current report filing (8-K)	NASDAQ:HEPH	Hollis-Eden Pharmaceuticals (MM)

검색 관련기사 보기:NASDAQ:HEPH

1 2 3 4 5 다음 >>

Energy Select Sector SPDR

Invesco QQQ Trust Series 1

BNP Paribas (QX)

US Dollar vs Yen

US Dollar vs Euro

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관